Joel Moss Selected Research

Poly Adenosine Diphosphate Ribose

2/2016	An enzyme-linked immunosorbent assay-based system for determining the physiological level of poly(ADP-ribose) in cultured cells.
11/2013	ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel Moss Research Topics

Disease

109	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 04/2024 - 03/2002
54	Tuberous Sclerosis (Bourneville's Disease) 04/2024 - 03/2002
50	Neoplasms (Cancer) 04/2024 - 09/2005
32	Lung Diseases (Lung Disease) 04/2024 - 12/2004
21	Angiomyolipoma 01/2019 - 12/2004
18	Cysts 04/2024 - 07/2006
18	Lymphangiomyoma 01/2018 - 02/2005
12	Inflammation (Inflammations) 02/2023 - 09/2003
11	Disease Progression 04/2024 - 02/2008
11	Carcinogenesis 02/2023 - 09/2005
11	Idiopathic Pulmonary Fibrosis 01/2021 - 12/2005
11	Pneumothorax 11/2017 - 12/2005
9	Dyspnea (Shortness of Breath) 01/2021 - 12/2005
8	Angiofibroma 03/2023 - 09/2005
7	Hamartoma 03/2023 - 12/2005
7	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 03/2002
7	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2007
6	Pleural Effusion (Pleural Effusions) 01/2018 - 04/2006
5	Melanoma (Melanoma, Malignant) 04/2024 - 02/2009
5	Rare Diseases (Rare Disease) 10/2023 - 12/2005
5	Fibrosis (Cirrhosis) 01/2022 - 09/2005
5	Diarrhea 12/2020 - 03/2002
5	Asthma (Bronchial Asthma) 01/2018 - 06/2006
5	Infections 12/2016 - 04/2002
5	Chylothorax 01/2016 - 12/2005
5	Fibroma (Fibromatosis) 11/2015 - 09/2005
5	Hemorrhage 03/2011 - 12/2005
5	Cystic Fibrosis (Mucoviscidosis) 06/2007 - 01/2002
4	Leiomyoma (Uterine Fibroids) 09/2013 - 03/2010
4	Lymphadenopathy 08/2013 - 05/2009
4	Hypoxia (Hypoxemia) 06/2013 - 12/2003
4	Adenocarcinoma 08/2006 - 05/2003
3	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2022 - 12/2005
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 09/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 05/2011
3	Sarcoidosis (Schaumann Disease) 01/2021 - 09/2009
3	Adenocarcinoma of Lung 01/2018 - 01/2003
3	Lymphatic Abnormalities 09/2012 - 12/2004
2	Seizures (Absence Seizure) 02/2023 - 06/2011
2	Cardiomegaly (Heart Hypertrophy) 02/2023 - 02/2012
2	Reperfusion Injury 11/2022 - 11/2018
2	Breast Neoplasms (Breast Cancer) 11/2021 - 02/2009
2	Rheumatoid Arthritis 01/2021 - 11/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 01/2013
2	Leukopenia 01/2018 - 01/2015
2	Ascites 08/2016 - 01/2007
2	Chylous Ascites 08/2016 - 11/2007

Drug/Important Bio-Agent (IBA)

90	lipoarabinomannan (LAM)IBA 04/2024 - 03/2002
42	trans-sodium crocetinate (crocetin)IBA 04/2024 - 12/2004
28	Sirolimus (Rapamycin)FDA Link 09/2023 - 09/2005
20	Proteins (Proteins, Gene)FDA Link 02/2023 - 04/2002
8	Mechanistic Target of Rapamycin Complex 1IBA 04/2024 - 01/2011
8	TOR Serine-Threonine KinasesIBA 11/2021 - 07/2006
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2013
7	Vascular Endothelial Growth Factor DIBA 01/2021 - 05/2009
7	Messenger RNA (mRNA)IBA 01/2018 - 07/2002
6	Cytotoxins (Cytolysins)IBA 12/2020 - 01/2002
6	Adenosine Diphosphate (ADP)IBA 01/2019 - 04/2002
5	Estrogens (Estrogen)FDA Link 01/2014 - 12/2004
4	HydrolasesIBA 02/2023 - 01/2018
4	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 02/2023 - 08/2011
4	CytokinesIBA 02/2023 - 09/2003
4	CollagenIBA 01/2022 - 09/2007
4	Oxygen (Dioxygen)IBA 01/2022 - 12/2003
4	Carbon MonoxideIBA 01/2021 - 01/2018
4	EnzymesIBA 12/2020 - 01/2006
3	Dobutamine FDA LinkGeneric 02/2023 - 11/2018
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2023 - 01/2019
3	Cholera ToxinIBA 12/2020 - 03/2002
3	Virulence Factors (Pathogenicity Factors)IBA 12/2020 - 03/2002
3	Bacterial ToxinsIBA 02/2020 - 01/2005
3	Arginine (L-Arginine)FDA Link 02/2020 - 12/2014
3	Bronchodilator Agents (Bronchodilators)IBA 01/2019 - 12/2009
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 08/2010
3	Melanoma-Specific AntigensIBA 03/2015 - 01/2008
3	human neutrophil peptide 1IBA 12/2014 - 06/2006
3	Tuberous Sclerosis Complex 2 ProteinIBA 01/2011 - 09/2005
3	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2008 - 03/2006
3	Progesterone FDA LinkGeneric 01/2005 - 07/2002
2	LuciferasesIBA 03/2024 - 08/2006
2	SolutionsIBA 10/2023 - 03/2002
2	Protein Kinases (Protein Kinase)IBA 02/2023 - 01/2020
2	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 02/2023 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 09/2013
2	SteroidsIBA 01/2020 - 02/2012
2	Galectin 3 (LGALS3)IBA 11/2017 - 03/2014
2	Small Interfering RNA (siRNA)IBA 12/2016 - 01/2013
2	LigandsIBA 10/2016 - 08/2007
2	Poly Adenosine Diphosphate RiboseIBA 02/2016 - 11/2013
2	MTOR InhibitorsIBA 01/2016 - 01/2015
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 09/2015 - 09/2007
2	Bcl-2-Like Protein 11IBA 09/2015 - 01/2013
2	AntibodiesIBA 05/2015 - 08/2013
2	Interleukin-6 (Interleukin 6)IBA 05/2015 - 03/2011
2	Hormones (Hormone)IBA 09/2013 - 02/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2011 - 07/2002

Therapy/Procedure

21	Therapeutics 01/2020 - 03/2002
8	Lung Transplantation 09/2022 - 12/2003
4	Pleurodesis 11/2017 - 04/2002
2	Nephrectomy 06/2011 - 01/2007